| DB ID | MyCo_3544 |
| Title | Comparison of galactomannan lateral flow assay and enzyme immunoassay to identify Aspergillus spp. in bronchoalveolar lavage fluid |
| Year | 2024 |
| PMID | 39009082 |
| Fungal Diseases involved | Fungal infection |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | This study was approved by the Research Ethics Commit-tee− CEP from the State University of Campinas, with the number of Certi cate of Presentation of Ethical Review (CAAE): 79558124.8.0000.5404. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Bronchoalveolar lavage fluid (BALF) |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Brazil |
| Cohort | A total of 71 samples, 37 (52.1 %) collected in 2019, 21 (29.6 %) in 2020, and 13 (18.3 %) in 2021 were analyzed. |
| Cohort No. | 71 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | Galactomannan lateral flow assay |
| ELISA kits | ELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA, Bio-Rad), Galactomannan lateral flow assay Kit (So~ na Aspergillus GM Lateral Flow Assay− IMMYÓ, Nor-man, Oklahoma, USA). |
| Assay Data | None |
| Validation Techniques used | FDA Approved -Platelia Aspergillus ELISA, Galactomannan lateral flow assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
